Secondary erythrocytosis

References

• Lee G, Arcasoy MO. The clinical and laboratory evaluation of the patient with erythrocytosis. Eur J Intern Med. 2015;26(5):297–302.
   PubMedGoogle Scholar
• Keohane C, McMullin MF, Harrison C. The diagnosis and management of erythrocytosis. BMJ. 2013;347(nov18 1):1–6.
   Google Scholar
• Wille K, Sadjadian P, Griesshammer M. Differentialdiagnose der Erythrozytose – ursachen und klinische Bedeutung. Dtsch Med Wochenschr. 2019;144(2):128–135.
   PubMedGoogle Scholar
• McMullin MF. Congenital erythrocytosis. Int J Lab Hematol. 2016;38(1):59–65.
   PubMedGoogle Scholar
• Barbui T, Thiele J, Gisslinger H, et al. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J. 2018;8(15):1–11.
   PubMedGoogle Scholar
• Mithoowani S, Laureano M, Crowther MA, et al. Investigation and management of erythrocytosis. CMAJ. 2020;192(32):E913–918.
   PubMed Web of Science ®Google Scholar
• McMullin M, Bareford D, Campbell P, et al. Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis. Br J Haematol. 2005;130(2):174–195.
   PubMed Web of Science ®Google Scholar
• Mallik N, Das R, Malhotra P. Congenital erythrocytosis. Eur J Haematol. 2021;107(1)29–37.
   PubMedGoogle Scholar
• Bento C. Genetic basis of congenital erythrocytosis. Int J Lab Hematol. 2018;40(1):62–67.
   PubMedGoogle Scholar
• Bento C, Percy MJ, Gardie B, et al. Genetic basis of congenital erythrocytosis: mutation update and online databases. Hum Mutat. 2014;35(1):15–26.
   PubMed Web of Science ®Google Scholar
• McMullin MF. Investigation and management of erythrocytosis. Curr Hematol Malig Rep. 2016;11(5)342–347.
   PubMed Web of Science ®Google Scholar
• Patnaik MM, Tefferi A. The complete evaluation of erythrocytosis: congenital and acquired. Leukemia. 2009;23(5):834–844.
   PubMedGoogle Scholar
• McMullin MF, Mead AJ, Ali S, et al. A guideline for the management of specific situations in polycythaemia and secondary erythrocytosis. A British Society for Haemtology Guideline. Br J Haematol. 2019;184(2):161–175.
   PubMedGoogle Scholar
• McMullin MF. Secondary erythrocytosis. Hematology. 2014;19(3):183–184.
   PubMed Web of Science ®Google Scholar
• Vlahakos DV, Marathias KP, Agroyannis B, et al. Posttransplant erythrocytosis. Kidney Int. 2003;63(4):1187–1194.
   PubMed Web of Science ®Google Scholar
• Ohlander SJ, Varghese B, Pastuszak AW. Erythrocytosis following testosterone therapy. Sex Med Rev. 2018;6(1):77–85.
   PubMed Web of Science ®Google Scholar
• Braekkan SK, Mathiesen EB, Niolstag I, et al. Hematocrit and risk of venous thromboembolism in general population. The Tromso study. Haematologica. 2010;95(2):270–275.
   PubMed Web of Science ®Google Scholar
• Moore-Gillon JC, Treacher DF, Gaminara EJ, et al. Intermittend hypoxia in patients with unexplained polycythaemia. BMJ. 1986;293(6547):588–590.
   PubMedGoogle Scholar
• Criner GJ. Effects of long-term oxygen therapy on mortality and morbidity. Respir Care. 2000;45(1):105–118.
   PubMedGoogle Scholar
• Tefferi A, Barbui T. Polycythemia vera a essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol. 2019;94(1):133–143.
   PubMed Web of Science ®Google Scholar
• Barrios-Ruiz A, Davila-Gonzales D, Fountain E, et al. Potential limitations of diagnostic standard codes to distinguish polycythemia vera and secondary erythrocytosis. Sci Rep. 2022;12(1):4674–4680.
   PubMedGoogle Scholar
• Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007;110(4):1092–1097.
   PubMed Web of Science ®Google Scholar
• Al-Rifai R, Vandestienne M, Lavillegrand JR, et al. JAK2 V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm. Nat Commun. 2022;13(1):6592.
   PubMedGoogle Scholar
• Wilkins BS, Erber WN, Bareford D, et al. Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes. Blood. 2008;111(1):60–70.
   PubMed Web of Science ®Google Scholar
• Silver RT, Chow W, Orazi A, et al. Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis. Blood. 2013;122(11):1881–1886.
   PubMed Web of Science ®Google Scholar
• McMullin MF, Harrison CN, Ali S, et al. BSH Committee. A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline. Br J Haematol. 2019;184(2):176–191.
   PubMed Web of Science ®Google Scholar
• Crockett AJ, Cranston JM, Moss JR, et al. Survival on long-term oxygen therapy in chronic airflow limitation: from evidence to outcomes in the routine clinical setting. Intern Med J. 2001;31(8):448–454.
   PubMed Web of Science ®Google Scholar
• Wouters HJCM, Mulder R, van Zeventer IA, et al. Erythrocytosis in the general population: clinical characteristics and association with clonal hematopoiesis. Blood Adv. 2020;4(24):6353–6363.
   PubMed Web of Science ®Google Scholar
• Griesshammer M. Risk factors for thrombosis and bleeding and their influence on therapeutic decisions in patients with essential thrombocythemia. Semin Thromb Hemost. 2006;32(4):372–380.
   PubMedGoogle Scholar
• Batt VR. Secondary polycythemia and the risk of venous thromboembolism. J Clin Med Res. 2014;6(5):395–397.
   PubMedGoogle Scholar
• Zhou AW, Knoche EM, Engle EK, et al. Clinical improvement with JAK2 inhibition in Chuvash polycythemia. N Engl J Med. 2016;375(5):494–496.
   PubMedGoogle Scholar